SJ
Satyendra Jain
About Satyendra Jain
Data last updated:
Satyendra Jain has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Vinca Labtech And Scientific Solutions Private Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Vinca Labtech And Scientific Solutions Private Limited at ₹2.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vinca Labtech And Scientific Solutions Private Limited U46596MP2023PTC065902 | Director | 25 May 2023 | 2023 | ₹2.34 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satyendra Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyendra Jain
Satyendra Jain has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Vinca Labtech And Scientific Solutions Private Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Vinca Labtech And Scientific Solutions Private Limited at ₹2.34 Cr (FY 2025).
Satyendra Jain is associated with 1 company as Director, including Vinca Labtech And Scientific Solutions Private Limited (₹2.34 Cr).
Satyendra Jain has expertise in Technology.
Satyendra Jain has 3 years in corporate governance.
By reported revenue, the largest current company of Satyendra Jain is Vinca Labtech And Scientific Solutions Private Limited, with revenue of ₹2.34 Cr (FY 2025).
Satyendra Jain currently holds positions at 1 company: Vinca Labtech And Scientific Solutions Private Limited (₹2.34 Cr).